Skip to main content
Clinical Trials/NL-OMON30469
NL-OMON30469CompletedPhase 3

A randomized trial in cancer-related fatigue in palliatively treated patients: protocolized patient-tailored treatment of physical symptoms (PPT) vs care as usual (CAU) - Cancer-related fatigue: systematic treatment of physical symptoms

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites152 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
152

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • a. Histologically or cytologically proven solid malignancy;
  • b. Curative treatment is not possible anymore;
  • c. Treated in the outpatient clinic;
  • d. Presence of fatigue scored as >=4 on a scale of 0 to 10;
  • e. Age >=18 years;
  • f. WHO performance status <= 2;
  • g. Life expectancy >= 3 months;
  • h. Able to write and speak Dutch;
  • i. Signed informed consent.

Exclusion Criteria

  • a. Concomitant (or within 4 weeks before randomization) administration
  • of any experimental drug;
  • b. Stay in a nursing home;
  • c. Untreated depression or anxiety disorders;
  • d. Severe comorbidity, e.g. heart failure or symptomatic chronic obstructive
  • lung disease
  • e. Cognitive limitations

Investigators

Similar Trials

A randomized trial in cancer-related... | Clinical Trial